Cultivation of stem cells extracted from amniotic fluid will help treat congenital conditions
New Pasteur Institute head highlights risks posed by shortages of money, staff and political goodwill
‘Brain fog’ detectable in long and short-term cases, detailed study suggests
‘Molecular factories’ boost field of synthetic biology, raising hopes of developing drugs and other products
Without scientific endeavour, we won’t have the tools we need to measure the planet’s pulse
January deadline will be first test of Britain’s prospects after three years away from the scheme
Paris university’s ‘radical decision’ to join OpenAlex challenges for-profit providers
Debates about crucial topics such as AI and net zero currently exclude large swaths of the population
Science secretary Michelle Donelan signs post-Brexit deal to rejoin €96bn research scheme
Use of technology to solve scientific problems still falls short of commercialisation
‘Treasure trove’ will be used to develop drugs and treatments for wide range of diseases and is culmination of 20 years of work
Government to boost spending on computing power by £500mn to develop artificial intelligence
Google DeepMind’s model beat world’s leading system in 90% of metrics used and took only a fraction of the time
Scientists hope rocks and dust taken from 4.7bn-year-old Bennu will provide clues to formation of solar system
Scientists and business welcome plan for Britain to go back into multilateral project
When it comes to academic papers, the line between fraud and substandard science can sometimes seem a little… academic
New model aims to reduce high development costs and increase number of drugs being tested
Joint work would avoid ‘deep scars’ caused by unequal access to drugs during Covid-19
‘Another Brick in the Wall’ study could help people with severe neurological damage to communicate
New research challenges idea that people have continuously lived in region since first arriving
If it wants to be an innovation superpower, the UK needs to rejoin €95bn EU programme
Move to terminate scientific project comes as Facebook parent prioritises moneymaking AI products over blue-sky research
Incipient industry will need decades, and many billions, before it becomes a commercial proposition
Scandals at Stanford and Harvard show manipulation of research remains an issue despite growth of ‘data detectives’
UK indecision about its place in the EU research programme is already damaging universities
